Press Releases

TEL AVIV, Israel and BETHESDA, Maryland, Feb. 11, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has signed a Memorandum Of Understanding with

LAS VEGAS, Feb. 11, 2020 /PRNewswire/ -- Snow may shut down mountain roads this winter, but it won't stop a Montana toddler from reaching the medical care she needs to win her fight against brain cancer. Two-year-old Joanna "Jojo" Hoskins from Great Falls has been battling medulloblastoma for

SCOTTSDALE, Ariz., Feb. 11, 2020 /PRNewswire/ -- Regen Suppliers announces the launch of a membership website, www.regensuppliers.com, that gives medical providers a designated sale

SOUTH SAN FRANCISCO, Calif., Feb. 11, 2020 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for cen

SAN DIEGO and PENNINGTON, N.J., Feb. 11, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced changes to its Board of Directors (the "Board") following the closing of the strategic investment by and partnersh

PALO ALTO, Calif., Feb. 11, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care. This new solution

FAIRWAY, Kan., Feb. 11, 2020 /PRNewswire/ -- Metactive Medical, Inc., a medical device company developing innovative products for peripheral vascular and neurovascular diseases, announced today that it has changed its name to Artio Medical, Inc. effective immediately.

SCOTTSDALE, Ariz., Feb. 11, 2020 /PRNewswire/ -- Assisted Living Locators, a nationwide senior care placement and referral service, announced they've partnered with Rehburg Life Settlements, a leading, nationally licensed life settlement brokerage, to provide families with an opportunity to help pay for long term care.

SAN DIEGO, Feb. 11, 2020 /PRNewswire/ -- Vividion Therapeutics, a biotechnology company discovering and developing highly selective small molecule medicines that drug traditionally inaccessible targets, today announced the appointment of Robert Abraham, Ph.D., as Chief Scientific Officer. Dr. Abraham joins Vividion from a 10-year tenure at

REDWOOD CITY, Calif., Feb. 11, 2020 /PRNewswire/ -- Talend (NASDAQ: TLND), a global leader in